XML 45 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021   20,437,692      
Beginning balance at Dec. 31, 2021 $ 609,159 $ 40 $ 1,043,600 $ (248) $ (434,233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)   43,997      
Issuance of common stock upon exercise of stock options and release of restricted stock units 236   236    
Stock-based compensation 77,879   77,879    
Other comprehensive (loss) income (2,046)     (2,046)  
Other, net (64)   (64)    
Net loss (149,564)       (149,564)
Ending balance (in shares) at Mar. 31, 2022   20,481,689      
Ending balance at Mar. 31, 2022 535,600 $ 40 1,121,651 (2,294) (583,797)
Beginning balance (in shares) at Dec. 31, 2021   20,437,692      
Beginning balance at Dec. 31, 2021 609,159 $ 40 1,043,600 (248) (434,233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive (loss) income (2,623)        
Net loss (212,175)        
Ending balance (in shares) at Jun. 30, 2022   20,956,666      
Ending balance at Jun. 30, 2022 486,460 $ 41 1,135,698 (2,871) (646,408)
Beginning balance (in shares) at Mar. 31, 2022   20,481,689      
Beginning balance at Mar. 31, 2022 535,600 $ 40 1,121,651 (2,294) (583,797)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)   474,977      
Issuance of common stock upon exercise of stock options and release of restricted stock units 617 $ 1 616    
Stock-based compensation 13,431   13,431    
Other comprehensive (loss) income (577)     (577)  
Net loss (62,611)       (62,611)
Ending balance (in shares) at Jun. 30, 2022   20,956,666      
Ending balance at Jun. 30, 2022 486,460 $ 41 1,135,698 (2,871) (646,408)
Beginning balance (in shares) at Dec. 31, 2022   21,068,697      
Beginning balance at Dec. 31, 2022 278,401 $ 41 1,153,031 (1,563) (873,108)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)   61,124      
Issuance of common stock upon exercise of stock options and release of restricted stock units 33   33    
Stock-based compensation 10,548   10,548    
Other comprehensive (loss) income 997     997  
Other, net 0        
Net loss (35,593)       (35,593)
Ending balance (in shares) at Mar. 31, 2023   21,129,821      
Ending balance at Mar. 31, 2023 254,386 $ 41 1,163,612 (566) (908,701)
Beginning balance (in shares) at Dec. 31, 2022   21,068,697      
Beginning balance at Dec. 31, 2022 $ 278,401 $ 41 1,153,031 (1,563) (873,108)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares) 7,953        
Other comprehensive (loss) income $ 1,391        
Net loss (57,581)        
Ending balance (in shares) at Jun. 30, 2023   21,170,092      
Ending balance at Jun. 30, 2023 247,471 $ 41 1,178,290 (172) (930,688)
Beginning balance (in shares) at Mar. 31, 2023   21,129,821      
Beginning balance at Mar. 31, 2023 254,386 $ 41 1,163,612 (566) (908,701)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)   40,271      
Issuance of common stock upon exercise of stock options and release of restricted stock units 34   34    
Stock-based compensation 14,644   14,644    
Other comprehensive (loss) income 394     394  
Other, net 0        
Net loss (21,987)       (21,987)
Ending balance (in shares) at Jun. 30, 2023   21,170,092      
Ending balance at Jun. 30, 2023 $ 247,471 $ 41 $ 1,178,290 $ (172) $ (930,688)